Histological regression in melanoma: impact on sentinel lymph node status and survival
| Autor: | Karina Aivazian, Andrew J. Spillane, Mary-Ann El Sharouni, Richard A. Scolyer, Tasnia Ahmed, John F. Thompson, Robyn P. M. Saw, Sydney Ch'ng, Kerwin F. Shannon, Omgo E. Nieweg, Jonathan R. Stretch, Serigne Lo |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Oncology
Pathology medicine.medical_specialty medicine.diagnostic_test Proportional hazards model business.industry Melanoma Sentinel lymph node medicine.disease Regression Pathology and Forensic Medicine Breslow Thickness Internal medicine Biopsy Cutaneous melanoma medicine Stage (cooking) business |
| Zdroj: | Modern Pathology. 34:1999-2008 |
| ISSN: | 0893-3952 |
| Popis: | Regression in melanoma is an immunological phenomenon that results in partial or complete replacement of the tumor with variably vascular fibrous tissue, often accompanied by pigment-laden macrophages and chronic inflammation. In some cases, tumor-infiltrating lymphocytes (TILs) may represent the earliest phase of this process. The prognostic significance of regression has long been a matter of debate, with inconsistent findings reported in the literature to date. This study sought to determine whether regression in primary cutaneous melanomas predicted sentinel lymph node (SLN) status and survival outcomes in a large cohort of patients managed at a single centre. Clinical and pathological parameters for 8,693 consecutive cases were retrieved. Associations between regression and SLN status, overall survival (OS), melanoma-specific survival (MSS) and recurrence-free survival (RFS) were investigated using logistic and Cox regression. Histological evidence of regression was present in 1958 cases (22.5%). Regression was significantly associated with lower Breslow thickness, lower mitotic rate, and absence of ulceration (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink